Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2011 Jun 6:6:61.
doi: 10.1186/1748-717X-6-61.

A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy

Affiliations
Comparative Study

A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy

Vitali Moiseenko et al. Radiat Oncol. .

Abstract

Background: Biological models are used to relate the outcome of radiation therapy to dose distribution. As use of biological models in treatment planning expands, uncertainties associated with the use of specific models for predicting outcomes should be understood and quantified. In particular, the question to what extent model predictions are data-driven or dependent on the choice of the model has to be explored.

Methods: Four dose-response models--logistic, log-logistic, Poisson-based and probit--were tested for their ability and consistency in describing dose-response data for radiation-induced optic neuropathy (RION) and retinopathy (RIRP). Dose to the optic nerves was specified as the minimum dose, Dmin, received by any segment of the organ to which the damage was diagnosed by ophthalmologic evaluation. For retinopathy, the dose to the retina was specified as the highest isodose covering at least 1/3 of the retinal surface (D33%) that geometrically covered the observed retinal damage. Data on both complications were modeled separately for patients treated once daily and twice daily. Model parameters D50 and γ and corresponding confidence intervals were obtained using maximum-likelihood method.

Results: Model parameters were reasonably consistent for RION data for patients treated once daily, D50 ranging from 94.2 to 104.7 Gy and γ from 0.88 to 1.41. Similar consistency was seen for RIRP data which span a broad range of complication incidence, with D50 from 72.2 to 75.0 Gy and γ from 1.51 to 2.16 for patients treated twice daily; 72.2-74.0 Gy and 0.84-1.20 for patients treated once daily. However, large variations were observed for RION in patients treated twice daily, D50 from 96.3 to 125.2 Gy and γ from 0.80 to 1.56. Complication incidence in this dataset in any dose group did not exceed 20%.

Conclusions: For the considered data sets, the log-logistic model tends to lead to larger D50 and lower γ compared to other models for all datasets. Statements regarding normal tissue radiosensitivity and steepness of dose-response, based on model parameters, should be made with caution as the latter are not only model-dependent but also sensitive to the range of complication incidence exhibited by clinical data.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Dose-response predicted by four studied models. Model parameters were commonly set to D50 = 80 Gy and γ = 1.5.
Figure 2
Figure 2
Incidence of radiation-induced optic neuropathy and dose-response curves predicted by studied four models. Horizontal error bars show standard deviation for dose for patients from each dose group, vertical error bars are 68% confidence intervals.
Figure 3
Figure 3
Incidence of radiation-induced retinopathy and dose-response curves predicted by studied four models. Horizontal error bars show standard deviation for dose for patients from each dose group, vertical error bars are 68% confidence intervals.
Figure 4
Figure 4
Log-likelihood function projected onto D50 (right panels) and γ (left panels) planes for optic neuropathy in patients treated once daily (a) and twice daily (b).
Figure 5
Figure 5
Log-likelihood function projected onto D50 (right panels) and γ (left panels) planes for retinopathy in patients treated once daily (a) and twice daily (b).

References

    1. Niemierko A, Urie M, Goitein M. Optimization of 3D radiation therapy with both physical and biological end points and constraints. Int J Radiat Oncol Biol Phys. 1992;23:99–108. doi: 10.1016/0360-3016(92)90548-V. - DOI - PubMed
    1. Sodertrom S, Brahme A. Optimization of the dose delivery in a few field techniques using radiobiological objective functions. Med Phys. 1993;20:1201–1210. doi: 10.1118/1.596971. - DOI - PubMed
    1. Alber M, Nusslin F. An objective function for radiation treatment optimization based on local biological measures. Phys Med Biol. 1999;44:479–493. doi: 10.1088/0031-9155/44/2/014. - DOI - PubMed
    1. Semenenko VA, Reitz B, Day E, Qi XS, Miften M, Li XA. Evaluation of a commercial biologically based IMRT treatment planning system. Med Phys. 2008;35:5851–5860. doi: 10.1118/1.3013556. - DOI - PubMed
    1. Yang Y, Xing L. Towards biologically conformal radiation therapy (BCRT): selective IMRT dose escalation under the guidance of spatial biology distribution. Med Phys. 2005;32:1473–1484. doi: 10.1118/1.1924312. - DOI - PubMed

Publication types